Precision Genomics for Rare Diseases: Shaping the Future of Treatment

Blog
Written By Namrata Khurana

The intersection of genomics and personalized medicine has transformed the landscape of healthcare. The Rare Genomics Institute (RG) emphasizes leveraging cutting-edge genomic technologies to identify the genetic basis of undiagnosed rare diseases and empowering patients with resources and the latest research. RG stands out from other organizations focused on rare diseases through its unique patient-centered approach. So far, RG has coordinated over 380 genetic sequencing projects and served over 825 families.

Below is the schema of the holistic approach used at RG to navigate the challenges of rare diseases, fostering a more comprehensive care ecosystem. 

At RG, we believe every rare disease patient deserves a diagnosis and a chance for a better future. With the power of genomics, innovation, collaboration and a community that cares, we are breaking barriers in rare disease research one story at a time. But we can’t do it alone.

Join us. Whether you are a researcher, clinician, donor or advocate, your support helps us bring hope to families still searching for answers.

Donate. Volunteer. Spread the word. Together, we can accelerate the journey from rare to known.

Namrata Khurana
Media Content Writer

Namrata Khurana is a Ph.D. trained biomedical writer with over a decade of experience in cancer biology, healthcare, drug discovery, immunology and genomics, gained through her research at leading institutions including Tulane University, Washington University in St. Louis, MD Anderson Cancer Center and Baylor College of Medicine. At Rare Genomics Institute, she contributes as a media content writer, crafting insightful blog articles about rare disease research and advocacy, with a focus on spreading awareness among the public and policymakers. Her work aims to bridge the gap between science and society; empowering patients, caregivers and decision-makers with reliable and meaningful information. Through her writing, she strives to make rare disease issues more visible and better understood.

Next

Funding challenges in Rare Disease Research: How financial support can transform the Rare Disease Landscape